New Delhi, July 11 -- Gland pharma is primarily a generic injectables manufacturing and CDMO (Contract Development and Manufacturing Outsourcing) company. Its growth will be driven by base operations ... Read More
New Delhi, July 11 -- Leo and Emraan meet in the office cafeteria over a cup of coffee, and the discussion moves from football to US FDA at a surprising pace. Leo: Hey, did you see the match yesterda... Read More
New Delhi, July 4 -- Home purchase is an important life event. So much so that, just as one insures health, life and motor vehicles, a home purchase should trigger an almost immediate purchase of term... Read More
New Delhi, July 4 -- Investor interest in Divis Laboratories continues to be robust on the back of growing demand for Indian CDMO (contract development and manufacturing outsourcing) services. In July... Read More
New Delhi, June 27 -- For India Inc., the business outlook for the near term remains mixed. The early months of the previous fiscal year (FY26) were clouded by tariff-related uncertainty, while the la... Read More
New Delhi, June 20 -- We had earlier recommended that investors accumulate Shyam Metalics in February 2025, when the stock was trading at Rs.711 per share, or 7.5 times one-year forward EV/EBITDA. The... Read More